NEPHROS, INC. Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
NEPHROS, INC. (NEPH) reported Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest of $276.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-15.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest · last filed 2024-03-15
- NEPHROS, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2022-12-31 was $70.00K, a 14.75% increase year-over-year.
- NEPHROS, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2022-09-30 was $77.00K, a 28.33% increase year-over-year.
- NEPHROS, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2022-06-30 was $66.00K, a 10.00% increase year-over-year.
- NEPHROS, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2022-03-31 was $63.00K, a 6.78% increase year-over-year.
- NEPHROS, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2022 was $276.00K, a 15.00% increase from fiscal 2021.
- NEPHROS, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2021 was $240.00K, a 0.00% change from fiscal 2020.
- NEPHROS, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2020 was $240.00K, a 0.41% decline from fiscal 2019.
- NEPHROS, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2019 was $241.00K.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $147.00K derived: sum of 2 quarters · filed 2024-03-15 | $213.00K derived: sum of 3 quarters · filed 2024-03-15 | $276.00K 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | $77.00K 10-Q · filed 2023-11-08 | $143.00K derived: sum of 2 quarters · filed 2023-11-08 | $206.00K 10-Q · filed 2023-11-08 | $267.00K derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $66.00K 10-Q · filed 2023-08-09 | $129.00K 10-Q · filed 2023-08-09 | $190.00K derived: sum of 3 quarters · filed 2023-08-09 | $250.00K derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $63.00K 10-Q · filed 2023-05-10 | $124.00K derived: sum of 2 quarters · filed 2023-05-10 | $184.00K derived: sum of 3 quarters · filed 2023-05-10 | $244.00K derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $121.00K derived: sum of 2 quarters · filed 2023-03-23 | $181.00K derived: sum of 3 quarters · filed 2023-03-23 | $240.00K 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | $60.00K 10-Q · filed 2022-11-15 | $120.00K derived: sum of 2 quarters · filed 2022-11-15 | $179.00K 10-Q · filed 2022-11-15 | $240.00K derived: sum of 4 quarters · filed 2022-11-15 | ||||
| 2021-06-30 | $60.00K 10-Q · filed 2022-08-15 | $119.00K 10-Q · filed 2022-08-15 | $180.00K derived: sum of 3 quarters · filed 2022-08-15 | $240.00K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $59.00K 10-Q · filed 2022-05-05 | $120.00K derived: sum of 2 quarters · filed 2022-05-05 | $180.00K derived: sum of 3 quarters · filed 2022-05-05 | $240.00K derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $121.00K derived: sum of 2 quarters · filed 2022-03-03 | $181.00K derived: sum of 3 quarters · filed 2022-03-03 | $240.00K 10-K · filed 2022-03-03 | ||||
| 2020-09-30 | $60.00K 10-Q · filed 2021-11-04 | -$60.00K 10-Q · filed 2020-11-05 | $120.00K derived: sum of 2 quarters · filed 2021-11-04 | $179.00K 10-Q · filed 2021-11-04 | -$179.00K 10-Q · filed 2020-11-05 | $600.00K derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | $60.00K 10-Q · filed 2021-08-05 | -$60.00K 10-Q · filed 2020-08-05 | $119.00K 10-Q · filed 2021-08-05 | -$119.00K 10-Q · filed 2020-08-05 | $540.00K derived: sum of 3 quarters · filed 2021-08-05 | $480.00K derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | $59.00K 10-Q · filed 2021-05-06 | -$59.00K 10-Q · filed 2020-05-06 | $480.00K derived: sum of 2 quarters · filed 2021-05-06 | $420.00K derived: sum of 3 quarters · filed 2021-05-06 | $359.00K derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | $421.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $361.00K derived: sum of 2 quarters · filed 2021-03-01 | $300.00K derived: sum of 3 quarters · filed 2021-03-01 | $241.00K 10-K · filed 2021-03-01 | -$241.00K 10-K · filed 2020-02-27 | |||
| 2019-09-30 | -$60.00K 10-Q · filed 2020-11-05 | -$121.00K derived: sum of 2 quarters · filed 2020-11-05 | -$180.00K 10-Q · filed 2020-11-05 | -$241.00K derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | -$61.00K 10-Q · filed 2020-08-05 | -$120.00K 10-Q · filed 2020-08-05 | -$181.00K derived: sum of 3 quarters · filed 2020-08-05 | -$197.00K derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-03-31 | -$59.00K 10-Q · filed 2020-05-06 | -$120.00K derived: sum of 2 quarters · filed 2020-05-06 | -$136.00K derived: sum of 3 quarters · filed 2020-05-06 | |||||
| 2018-12-31 | -$61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$77.00K derived: sum of 2 quarters · filed 2020-02-27 | -$77.00K 10-K · filed 2020-02-27 | |||||
| 2018-09-30 | -$16.00K 10-Q · filed 2019-11-06 | -$16.00K 10-Q · filed 2019-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |